CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

The Carlyle Group buys Vectura Group in £958m deal

By Dan Moore

08:27, 26 May 2021

The Carlyle Group logo on a laptop computer

Vectura Group, a pharmaceutical company that concentrates on inhaled medicines, has been purchased by global investor The Carlyle Group for £958m ($1.36bn).

As a result of the agreement, which was announced early on Wednesday, shareholders will get 136p in cash, plus a 19p a share dividend, which represents a 32% premium on the ex-dividend closing price as of Tuesday.

Leading inhaled product provider

The purchase of Vectura marks the latest development in the company, which set out its plans to become a leading inhalation-centred contract development and manufacturing organisation just two years ago.

Vectura provides 13 key inhaled and 11 non-inhaled medical products, including the Flutiform asthma drug, which are marketed by partners, including Novartis, GSK, Bayer and Tianjin KingYork, with global royalty streams.

ETH/USD

3,570.17 Price
+0.160% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

XRP/USD

0.63 Price
-1.550% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

18,249.40 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

Gold

2,233.43 Price
+1.740% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.80

Vectura shares leapt 31% to 160p following the announcement that the pharmaceutical firm had been purchased by US private equity company The Carlyle Group.

What is your sentiment on ETH/USD?

3570.17
Bullish
or
Bearish
Vote to see Traders sentiment!

“An attractive offer”

Commenting on the takeover Vectura chairman Bruno Angelici said: “While the Vectura directors remain confident in the long-term fundamentals of the Vectura Group, we believe that this is an attractive offer for Vectura Shareholders, which secures the delivery of future value for Vectura Shareholders in cash today.

“The offer reflects the quality, strength and long-term performance of Vectura’s businesses and its future growth potential. We believe that our people, our clients and our businesses will continue to prosper under the stewardship of Carlyle.”

1m
5m
15m
30m
1H
4H
1D
1W

Read more: Best stocks to invest in 2021: where to put your money as Covid-19 vaccines raise recovery hopes

Rate this article

Capital Com is an execution-only service provider. The material provided in this article is for information purposes only and should not be understood as investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents and has not been prepared in accordance with the legal requirements designed to promote investment research independence. While the information in this communication, or on which this communication is based, has been obtained from sources that Capital.com believes to be reliable and accurate, it has not undergone independent verification. No representation or warranty, whether expressed or implied, is made as to the accuracy or completeness of any information obtained from third parties. If you rely on the information on this page, then you do so entirely at your own risk.

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading